Functional analysis of LDLR promoter and 5′ UTR mutations in subjects with clinical diagnosis of familial hypercholesterolemia

Familial hypercholesterolemia (FH) is a dominant disorder due to mutations in the LDLR gene. Several mutations in the LDLR promoter are associated with FH. Screening of 3,705 Spanish FH patients identified 10 variants in the promoter and 5′ UTR. Here, we analyse the functionality of six newly identified LDLR variants. Mutations located in the LDLR promoter regulatory elements R2 and R3 (c.−155_‐150delACCCCinsTTCTGCAAACTCCTCCC, c.−136C>G, c.−140C>G, and c.−140C>T) resulted in 6 to 15% residual activity in reporter expression experiments and changes in nuclear protein binding affinity compared to wild type. No reduction was observed when cells were transfected with c.−208T, c.−88A, and c.−36G mutant fragments. Our results indicate that mutations localized in R2 and R3 are associated with hypercholesterolemia, whereas mutations outside the LDLR response elements are not a cause of FH. This data emphasizes the importance of functional analysis of variants in the LDLR promoter to determine their association with the FH phenotype.Hum Mutat 32:1–5, 2011. © 2011 Wiley‐Liss, Inc.

[1]  T. Südhof,et al.  Three direct repeats and a TATA-like sequence are required for regulated expression of the human low density lipoprotein receptor gene. , 1987, The Journal of biological chemistry.

[2]  Jingwen Liu,et al.  Identification of a Novel Sterol-independent Regulatory Element in the Human Low Density Lipoprotein Receptor Promoter* , 2000, The Journal of Biological Chemistry.

[3]  S. Humphries,et al.  FH‐Pyrgos: a novel mutation in the promoter (−45delT) of the low‐density lipoprotein receptor gene associated with familial hypercholesterolemia , 2003, Clinical genetics.

[4]  A. Munnich,et al.  Molecular Spectrum of Autosomal Dominant Hypercholesterolemia in France , 2010, Human mutation.

[5]  E. Ros,et al.  Promoter variant -204A > C of the cholesterol 7α-hydroxylase gene: association with response to plant sterols in humans and increased transcriptional activity in transfected HepG2 cells. , 2011, Clinical nutrition.

[6]  H. Francová,et al.  New promoter mutations in the low-density lipoprotein receptor gene which induce familial hypercholesterolaemia phenotype: Molecular and functional analysis , 2004, Journal of Inherited Metabolic Disease.

[7]  H. Hobbs,et al.  Molecular genetics of the LDL receptor gene in familial hypercholesterolemia , 1992, Human mutation.

[8]  X. Wang,et al.  Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. II. Purification and characterization. , 1993, The Journal of biological chemistry.

[9]  O. Jänne,et al.  A single-base substitution in the proximal Sp1 site of the human low density lipoprotein receptor promoter as a cause of heterozygous familial hypercholesterolemia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  K. Mehta,et al.  Identification of a Novel cis-Acting Element Participating in Maximal Induction of the Human Low Density Lipoprotein Receptor Gene Transcription in Response to Low Cellular Cholesterol Levels* , 1996, The Journal of Biological Chemistry.

[11]  M. Eriksson,et al.  Genetic characterization of Swedish patients with familial hypercholesterolemia: a heterogeneous pattern of mutations in the LDL receptor gene. , 2002, Atherosclerosis.

[12]  T. Cox.  The metabolic and molecular bases of inherited disease: Vols I, II and III (7th edn): edited by Charles R. Scriver, Arthur L. Beaudet, William S. Sly and David Valle McGraw-Hill, 1995, £195.00 hbk (4605 pages) ISBN 0 07 909826 6 , 1996 .

[13]  A. Admon,et al.  SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene , 1993, Cell.

[14]  A. Marais,et al.  Mutation -59c-->t in repeat 2 of the LDL receptor promoter: reduction in transcriptional activity and possible allelic interaction in a South African family with familial hypercholesterolaemia. , 1999, Human molecular genetics.

[15]  T. Farag,et al.  Familial hypercholesterolemia. , 1988, Journal of the Royal Society of Medicine.

[16]  T. Südhof,et al.  Sterol-dependent repression of low density lipoprotein receptor promoter mediated by 16-base pair sequence adjacent to binding site for transcription factor Sp1. , 1988, The Journal of biological chemistry.

[17]  A. Soutar,et al.  A mutation (T-45C) in the promoter region of the low-density-lipoprotein (LDL)-receptor gene is associated with a mild clinical phenotype in a patient with heterozygous familial hypercholesterolaemia (FH). , 1995, Human molecular genetics.

[18]  M. Pocovi,et al.  Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia. , 2005, Clinical chemistry.

[19]  J. R. Smith,et al.  Identification of nucleotides responsible for enhancer activity of sterol regulatory element in low density lipoprotein receptor gene. , 1990, The Journal of biological chemistry.

[20]  Jingwen Liu,et al.  Identification of Heterogeneous Nuclear Ribonucleoprotein K as a Transactivator for Human Low Density Lipoprotein Receptor Gene Transcription* , 2010, The Journal of Biological Chemistry.

[21]  M. Brown,et al.  Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. I. Identification of the protein and delineation of its target nucleotide sequence. , 1993, The Journal of biological chemistry.

[22]  S. Humphries,et al.  The molecular basis of familial hypercholesterolaemia in Turkish patients. , 2005, Atherosclerosis.

[23]  R. Galetto,et al.  A mutation (-49C>T) in the promoter of the low density lipoprotein receptor gene associated with familial hypercholesterolemia. , 2002, Journal of lipid research.

[24]  S E Humphries,et al.  Update and Analysis of the University College London Low Density Lipoprotein Receptor Familial Hypercholesterolemia Database , 2008, Annals of human genetics.

[25]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[26]  S. Humphries,et al.  A functional mutation in the LDLR promoter (−139C>G) in a patient with familial hypercholesterolemia , 2007, European Journal of Human Genetics.